Orion Oyj Series A | Key People and Executives
Heikki Seppo Westerlund
Chairman
Ari Tapio Lehtoranta
Director
Mikael Silvennoinen
Director
Timo Tuomas Mikael Maasilta
Vice Chairman
Sirpa Tuulikki Jalkanen
Independent Director
Heikki Seppo Westerlund
Chairman
Timo Antero Lappalainen
President & Chief Executive Officer
Jari Karlson
CFO, SVP-Animal Health & IR Contact
Christer Nordstedt
Senior Vice President-Research & Development
Heikki Joensuu
Vice President-Therapy Area Oncology, R&D
Virve Laitinen
Senior Vice President-Supply Chain
Markku Huhta-Koivisto
Senior Vice President-Proprietary Products
Liisa Hurme
Senior Vice President-Specialty Products
Ari Tapio Lehtoranta
Director
Mikael Silvennoinen
Director
Satu Ahomäki
Senior Vice President-Global Sales
Paula Rytilä
Medical Director & Investor Relations Contact
Heidi Ahti
Executive Assistant & IR Coordinator
Annukka Linnakylä
Investor Relations Contact
Olli Huotari
Secretary & SVP-Corporate Functions
Timo Tuomas Mikael Maasilta
Vice Chairman
Sirpa Tuulikki Jalkanen
Independent Director
| Address |
Orionintie 1A
Espoo UU 02200
Finland
|
|
Employees
|
- |
| Website |
http://www.orion.fi |
| Updated |
07/08/2019 |
| Orion Oyj engages in the development of pharmaceutical and diagnostic test. It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Its pharmaceutical research and development focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. |
